LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.06 | 27.76 | 688 | 360 | 1.9111 | 1.3830 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.06 | 27.76 | 666 | 360 | 1.8500 | 1.3621 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.06 | 27.76 | 902 | 360 | 2.5056 | 1.5641 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.76 | 27.76 | 715 | 401 | 1.7824 | 1.3237 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.76 | 27.76 | 738 | 401 | 1.8397 | 1.3428 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 8.76 | 27.76 | 1007 | 401 | 2.5103 | 1.5396 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.46 | 27.76 | 772 | 438 | 1.7600 | 1.3051 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.46 | 27.76 | 778 | 438 | 1.7737 | 1.3096 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.46 | 27.76 | 27 | 438 | 0.0616 | -0.0069 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.46 | 27.76 | 1071 | 438 | 2.4416 | 1.5026 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.17 | 27.76 | 779 | 489 | 1.5928 | 1.2381 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.17 | 27.76 | 770 | 489 | 1.5744 | 1.2318 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.17 | 27.76 | 65 | 489 | 0.1329 | 0.2282 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.17 | 27.76 | 1120 | 489 | 2.2901 | 1.4433 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.87 | 27.76 | 800 | 604 | 1.3229 | 1.1300 | MN20160318_Q01 | D18 |